Second hip fracture in elderly hip fracture patients: Cost and effectiveness of fracture prevention treatment [5]

Age and Ageing

Volumn 34, Issue 5, 2005, Pages 507-510

  Segal, E ^a   Zinnman, C ^a   Raz, B ^a   Tamir, A ^b,c   Gurevich, B ^a   Siebzehner, M I ^d   Ish Shalom, S ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d MINISTRY OF HEALTH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; COLECALCIFEROL; RALOXIFENE;

AGED; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; FEMALE; FRAGILITY FRACTURE; HEALTH PROGRAM; HEALTH SURVEY; HIP FRACTURE; HIP SURGERY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT; SENILE OSTEOPOROSIS; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION;

AGED; ALENDRONATE; CALCIUM; CHOLECALCIFEROL; COSTS AND COST ANALYSIS; HIP FRACTURES; HUMANS; OSTEOPOROSIS; RECURRENCE;

EID: 24644513878     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afi136     Document Type: Letter

References (23)

1. Eastell R, Reid DM, Compston J et al. Secondary prevention of osteoporosis: When should a non-vertebral fracture be a trigger for action? QJM 2001; 94: 575-97.
2. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359: 1761-7.
3. Bischoff HA, Solomon DH, Dawson-Hughes B et al. Repeat hip fractures in a population-based sample of Medicare recipients in the US: rates, timing and gender differences. J Bone Min Res 2001; 16(Suppl 1): 291.
4. Dolk T. Influence of treatment factors on the outcome after hip fractures. Uppsala J Med Sci 1989; 94: 209-21.
5. Chapuy MC, Meunier PJ. Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements. Osteoporos Int 1996; 6(Suppl 3): 60-3.
6. Fox KM, Magaziner J, Hawkes WG et al. Loss of bone density and lean body mass after hip fracture. Osteoporos Int 2000; 11: 31-5.
7. Dretakis KE, Dretakis EK, Papakitsou EF, Psarakis S, Steriopoulos K. Possible predisposing factors for the second hip fracture. Calc Tissue Int 1998; 62: 366-9.
8. Kamel HK, Duthie EH. The underuse of therapy in the secondary prevention of hip fractures. Drugs Aging 2002; 19: 1-10.
9. Cuddihy MT, Gabriel SE, Crowson CS et al. Osteoporosis intervention following distal forearm fractures: A missed opportunity? Arch Intern Med 2002; 162: 421-6.
10. Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 2000; 163: 819-22.
11. Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998; 57: 378-9.
12. Liberman UA, Weiss SR, Broll J et al. Effect of oral alendronate on bone mineral density and the incidence of fractures on postmenopausal osteoporosis. The Alendonate Phase 111 Osteoporosis Treatment Study Group. N Engl J Med 1995; 333: 1437-43.
13. Ettinger MP. Aging bone and osteoporosis: Strategies for preventing fractures in the elderly. Arch Intern Med 2003; 163: 2237-46.
14. Siris ES, Bilezikian JP, Rubin MR et al. Pins and plaster aren't enough: A call for the evaluation and treatment of patients with osteoporotic fractures. JCEM 2003; 88: 3482-6.
15. Juby AG, De Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 2002; 13: 205-10.
16. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joint Surg 2000; 82A: 1063-70.
17. Liel Y, Castel H, Bonneh DY. Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures. Osteoporos Int 2003; 14: 490-5.
18. Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 2002; 13: 450-5.
19. Segal E, Zinnman H, Raz B, Tamir A, Ish-Shalom S. Adherence to vitamin D supplementation in elderly patients after hip fracture. J Am Geriatric Soc 2004; 52: 474-5.
20. McLellan AR, Fraser M. A 28-month audit of the efficacy of the fracture liaison service in offering secondary prevention for patients with osteoporotic fractures. J Bone Min Res 2002; 17(Suppl 1): 358.
21. Paccione P, Powell R, O'Neill J, Weiss TW. Impact of an educational intervention for the prevention and treatment of osteoporosis: A health plan's perspective. J Bone Min Res 2002; 17(Suppl 1): 477.
22. Werner P, Olchovsky D, Shemi G, Vered I. Osteoporosis health-related behaviors in secular and orthodox Israeli Jewish women. Maturitas 2003; 46: 283-94.
23. Werner P, Vered I. The diagnosis of osteoporosis: Attitudes and knowledge of Israeli physicians. Aging Clin Exp Res 2002; 14: 52-9.